Payment overview · 2025
General Payments
$21.27
1 reported records · 1 companies
Healthcare provider profile · identity verified
Eric E. Kim, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CLEARLAKE, CA · NPI 1578660916
Verified facts
What the public records show
CMS Open Payments records show Eric E. Kim, MD received $21.27 in general payments during 2025 across 1 reported records.
Astellas Pharma US Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 60 claims for Myrbetriq by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $21.27 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.27 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Xtandi Normalized: xtandi |
Drug | Astellas Pharma US Inc | $21.27 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
60 | 19 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1034 | 232 |
| Pantoprazole Sodium | Pantoprazole Sodium | 850 | 179 |
| Levothyroxine Sodium | Levothyroxine Sodium | 794 | 152 |
| Amlodipine Besylate | Amlodipine Besylate | 537 | 112 |
| Gabapentin | Gabapentin | 480 | 105 |
| Metformin Hcl | Metformin Hcl | 416 | 91 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 396 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 344 | 75 |
| Trazodone Hcl | Trazodone Hcl | 341 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 321 | 96 |
| Omeprazole | Omeprazole | 314 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 312 | 65 |
| Telmisartan | Telmisartan | 308 | 74 |
| Tramadol Hcl | Tramadol Hcl | 292 | 59 |
| Lisinopril | Lisinopril | 282 | 68 |
| Meloxicam | Meloxicam | 273 | 56 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 260 | 43 |
| Montelukast Sodium | Montelukast Sodium | 253 | 39 |
| Potassium Chloride | Potassium Chloride | 251 | 56 |
| Losartan Potassium | Losartan Potassium | 243 | 56 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 227 | 55 |
| Simvastatin | Simvastatin | 216 | 47 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 207 | 37 |
| Rybelsus | Semaglutide | 201 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 195 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 194 | 45 |
| Ibuprofen | Ibuprofen | 187 | 56 |
| Carvedilol | Carvedilol | 181 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 180 | 28 |
| Furosemide | Furosemide | 174 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 171 | 35 |
| Jardiance | Empagliflozin | 170 | 37 |
| Spironolactone | Spironolactone | 169 | 37 |
| Glimepiride | Glimepiride | 138 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 137 | 26 |
| Ozempic | Semaglutide | 131 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 127 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 125 | 25 |
| Pregabalin | Pregabalin | 119 | 28 |
| Breo Ellipta | Fluticasone/Vilanterol | 118 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 118 | 23 |
| Lorazepam | Lorazepam | 117 | 43 |
| Alprazolam | Alprazolam | 116 | 21 |
| Famotidine | Famotidine | 116 | 24 |
| Ondansetron Odt | Ondansetron | 106 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 105 | 15 |
| Allopurinol | Allopurinol | 99 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 96 | 21 |
| Celecoxib | Celecoxib | 94 | 34 |
| Eliquis | Apixaban | 93 | 24 |
| Trulicity | Dulaglutide | 92 | 12 |
| Sertraline Hcl | Sertraline Hcl | 91 | 26 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 34 |
| Amitriptyline Hcl | Amitriptyline Hcl | 84 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 84 | 25 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 83 | 18 |
| Bupropion Xl | Bupropion Hcl | 82 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 82 | 14 |
| Buspirone Hcl | Buspirone Hcl | 77 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 77 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 72 | 14 |
| Naproxen | Naproxen | 71 | 15 |
| Baclofen | Baclofen | 70 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | 17 |
| Alendronate Sodium | Alendronate Sodium | 69 | 15 |
| Glipizide | Glipizide | 69 | 13 |
| Mirtazapine | Mirtazapine | 65 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 14 |
| Meclizine Hcl | Meclizine Hcl | 63 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 21 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 62 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 60 | suppressed |
| Myrbetriq | Mirabegron | 60 | 19 |
| Sumatriptan Succinate | Sumatriptan Succinate | 59 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 58 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 55 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 55 | 12 |
| Atenolol | Atenolol | 54 | 12 |
| Topiramate | Topiramate | 54 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 52 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 48 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 47 | suppressed |
| Levetiracetam | Levetiracetam | 46 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 42 | suppressed |
| Aripiprazole | Aripiprazole | 41 | suppressed |
| Finasteride | Finasteride | 39 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 38 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 37 | suppressed |
| Clonazepam | Clonazepam | 36 | suppressed |
| Lovastatin | Lovastatin | 36 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Azithromycin | Azithromycin | 33 | 31 |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 22 |
| Econazole Nitrate | Econazole Nitrate | 31 | 15 |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 31 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 30 | suppressed |
| Calcitriol | Calcitriol | 29 | suppressed |
| Levofloxacin | Levofloxacin | 29 | 25 |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | suppressed |
| Estradiol | Estradiol | 28 | 11 |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | suppressed |
| Acyclovir | Acyclovir | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 18 |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Ibu | Ibuprofen | 27 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 27 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 22 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 20 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | suppressed |
| Prednisone | Prednisone | 24 | 13 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 23 | 14 |
| Divalproex Sodium | Divalproex Sodium | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Xarelto | Rivaroxaban | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Armour Thyroid | Thyroid,pork | 17 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Indomethacin | Indomethacin | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 14 | 14 |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Xifaxan | Rifaximin | 14 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Alogliptin | Alogliptin Benzoate | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Fluocinonide | Fluocinonide | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Apidra Solostar | Insulin Glulisine | 11 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Dotti | Estradiol | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Metaxalone | Metaxalone | 11 | suppressed |
| Nabumetone | Nabumetone | 11 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Wellbutrin Sr | Bupropion Hcl | 11 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.27 · 1 records | Astellas Pharma US Inc | Xtandi | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error